rethinkPeptides Search
Menu
Study breakdown

Mapping the Neurotransmitter Imbalances Behind Cluster Headache Attacks

Systematic ReviewModerate evidence
The takeaway

Systematic review reveals inconsistent but significant neurotransmitter and neuropeptide changes in cluster headache, highlighting key knowledge gaps and promising therapeutic targets.

Inconsistent results across studies

While multiple neurochemical changes have been reported in cluster headache, study results do not always agree, highlighting the need for standardized research

What the researchers found

Multiple neurotransmitter and neuropeptide changes have been identified in cluster headache, but study results are inconsistent, highlighting gaps in understanding the neurochemical basis of attacks.

Why it matters

Cluster headache remains poorly treated despite its severity. Identifying the specific neurochemical imbalances driving attacks could lead to more targeted and effective therapies.

The numbers in context

38 studies included. Searched PubMed, Embase, Scopus. Assessed neurotransmitters in plasma, saliva, CSF, and platelets. Histamine and sensory neuropeptides (CGRP, substance P) most consistently altered.

How the study worked

Systematic review of PubMed, Embase (Ovid), and Scopus for studies reporting quantitative neurotransmitter measurements in cluster headache patients.

Who was studied

People with cluster headache

What this study cannot tell us

Inconsistent findings across studies may reflect differences in methodology, sample timing, and patient populations. Small sample sizes in many individual studies.

How to read the evidence

Systematic review of observational studies — methodologically strong but limited by the inconsistency of the underlying evidence base.

When this study was published

Published in 2025, providing the most current synthesis of cluster headache neurochemistry.

The bigger picture

This review creates a roadmap for future cluster headache research by clearly identifying which neurochemical pathways have the strongest evidence and where more work is needed.

Questions still open

  • Which specific neuropeptide pathways are most consistently altered during cluster headache attacks?
  • Could targeting multiple neurotransmitter systems simultaneously improve cluster headache treatment?

Common questions

What causes cluster headache attacks?
The exact cause is still unclear. This review shows that multiple neurotransmitters and neuropeptides are involved, but studies do not always agree on which changes are most important. The hypothalamus and trigeminal nerve system are believed to play central roles.
Will this research lead to better cluster headache treatments?
Potentially. By identifying the most promising neurochemical targets and highlighting where evidence is lacking, this review creates a roadmap for developing more targeted therapies for cluster headache.

Read the original research

Neurotransmitter Imbalance in Cluster Headache: A Systematic Review of Mechanisms and Therapeutic Targets.

Pain and therapy, 14(6), 1629-1645

Citation

Pellesi, Lanfranco; Mohammad, Anas; Wang, Wei; Martelletti, Paolo. (2025). Neurotransmitter Imbalance in Cluster Headache: A Systematic Review of Mechanisms and Therapeutic Targets.. Pain and therapy, 14(6), 1629-1645. https://doi.org/10.1007/s40122-025-00778-8